Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A
2011

Gene Expression Changes in Cryptococcus neoformans After Fluconazole Treatment

Sample size: 6823 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ada Rita Florio, Selene Ferrari, Elena De Carolis, Riccardo Torelli, Giovanni Fadda, Maurizio Sanguinetti, Dominique Sanglard, Brunella Posteraro

Primary Institution: Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy

Hypothesis

What are the changes in gene expression of Cryptococcus neoformans in response to fluconazole treatment?

Conclusion

Short-term exposure of Cryptococcus neoformans to fluconazole resulted in a complex altered gene expression profile, indicating adaptive responses to the antifungal agent.

Supporting Evidence

  • 476 genes were found to be responsive to fluconazole treatment.
  • Up-regulation of genes involved in ergosterol biosynthesis was observed.
  • Expression of the major azole transporter gene AFR1 was not regulated by fluconazole.

Takeaway

When a fungus called Cryptococcus neoformans is treated with a medicine called fluconazole, it changes how it uses its genes to survive.

Methodology

The study involved genome-wide transcriptional profiling of over 6823 genes in Cryptococcus neoformans after exposure to fluconazole.

Limitations

The study focused on a single strain and a specific concentration and time point of fluconazole exposure.

Statistical Information

P-Value

< 0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2180-11-97

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication